Xyloketal B exerts antihypertensive effect in renovascular hypertensive rats via the NO-sGC-cGMP pathway and calcium signaling

MLA

Zhao, Li-yan, et al. “Xyloketal B Exerts Antihypertensive Effect in Renovascular Hypertensive Rats via the NO-SGC-CGMP Pathway and Calcium Signaling.” Acta Pharmacologica Sinica, vol. 39, no. 5, May 2018, pp. 875–84. EBSCOhost, https://doi.org/10.1038/aps.2018.12.

APA

Zhao, L., Li, J., Huang, X., Wang, G., Lv, X., Meng, W., Chen, W., Pang, J., Lin, Y., Sun, H., Wang, G., & Du, Y. (2018). Xyloketal B exerts antihypertensive effect in renovascular hypertensive rats via the NO-sGC-cGMP pathway and calcium signaling. Acta Pharmacologica Sinica, 39(5), 875–884. https://doi.org/10.1038/aps.2018.12

Chicago

Zhao, Li-yan, Jie Li, Xiong-qing Huang, Guo-hao Wang, Xiao-fei Lv, Wei-feng Meng, Wen-liang Chen, et al. 2018. “Xyloketal B Exerts Antihypertensive Effect in Renovascular Hypertensive Rats via the NO-SGC-CGMP Pathway and Calcium Signaling.” Acta Pharmacologica Sinica 39 (5): 875–84. doi:10.1038/aps.2018.12.